Primary Site >> Stomach Cancer
Gene >> SPTBN1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: New developments in the treatment of gastric carcinoma. PMID: 2305269 Ref: High dose folinic acid/etoposide/5-fluorouracil in advanced gastric cancer--a phase II study in elderly patients or patients with cardiac risk. PMID: 2345071 |
Ref: New developments in the treatment of gastric carcinoma. PMID: 1681867 Ref: Etoposide, folinic acid, and 5-fluorouracil in carboplatin-pretreated patients with advanced gastric cancer. PMID: 1742854 Ref: Perspectives in chemotherapy of advanced gastric cancer. PMID: 1835661 Ref: Current strategies in the management of locoregional and metastatic gastric carcinoma. PMID: 1984825 |
Ref: Etoposide, leucovorin, 5-fluorouracil (ELF) combination chemotherapy for advanced gastric cancer: experience with two treatment schedules incorporating intravenous or oral etoposide. PMID: 8172800 |
Ref: Etoposide, leucovorin and 5-fluorouracil in advanced gastric cancer: a phase II study. PMID: 7645929 Ref: Chemotherapy in gastric cancer: an economic evaluation of the FAM (5-fluorouracil, adriamycin, mitomycin C) versus ELF (etoposide, leucovorin, 5-fluorouracil) regimens. PMID: 8596132 |
Ref: Treatment of advanced gastric cancer with a modified regimen of etoposide/leucovorin/5-fluorouracil. PMID: 8630679 Ref: The treatment of advanced gastric cancer. PMID: 8658224 Ref: Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group. PMID: 8673994 Ref: Chemotherapy of gastric cancer. PMID: 8740718 Ref: Phase II trial of N-(phosphonacetyl)-L-aspartate (PALA), 5-fluorouracil and recombinant interferon-alpha-2b in patients with advanced gastric carcinoma. PMID: 8758262 Ref: A phase II trial of etoposide, leucovorin and 5-fluorouracil (ELF) in patients with advanced gastric cancer. PMID: 8873837 Ref: A randomized trial comparing adjuvant fluorouracil, epirubicin, and mitomycin with no treatment in operable gastric cancer. PMID: 8983891 |
Ref: [The role of antitumor drugs in treating stomach cancer patients]. PMID: 9173567 Ref: A phase II trial of paclitaxel and weekly 24 h infusion of 5-fluorouracil/folinic acid in patients with advanced gastric cancer. PMID: 9180395 |
Ref: [Neo-adjuvants, adjuvants and palliative therapy for gastric carcinoma]. PMID: 9584571 Ref: [Advanced gastric cancer curatively resected following combined neoadjuvant chemotherapy--report of a case]. PMID: 9617332 Ref: Phase II study of the modified regimen of etoposide, leucovorin and 5-fluorouracil for patients with advanced gastric cancer. PMID: 9703859 Ref: Treatment of advanced gastric cancer with oral etoposide, leucovorin and tegafur: experience with an oral modification of the etoposide, leucovorin and 5-fluorouracil (ELF) regimen. PMID: 9849466 |
Ref: Combination chemotherapy with granulocyte-macrophage-colony stimulating factor in patients with locoregional and metastatic gastric adenocarcinoma. PMID: 10357402 Ref: CPT-11 in gastrointestinal cancer. PMID: 10448285 Ref: Mitomycin C continuous infusion as salvage chemotherapy in pretreated patients with advanced gastric cancer. PMID: 10573205 |
Ref: Neoadjuvant chemotherapy with P-ELF (cisplatin, etoposide, leucovorin, 5-fluorouracil) followed by radical resection in patients with initially unresectable gastric adenocarcinoma: a phase II study. PMID: 10674448 Ref: Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the Europe PMID: 10894863 Ref: [Preliminary clinical comparison of HLF and ELF regimen in the treatment of advanced gastric carcinoma in middle-aged and elderly patients]. PMID: 11778280 |
Ref: Sequence-specific enhancer binding protein is responsible for the differential expression of ERT/ESX/ELF-3/ESE-1/jen gene in human gastric cancer cell lines: Implication for the loss of TGF-beta type II receptor expression. PMID: 11313868 |
Ref: Polysaccharides isolated from Echinacea purpurea herba cell cultures to counteract undesired effects of chemotherapy--a pilot study. PMID: 11933115 Ref: Treatment of advanced gastric cancer with etoposide, folinic acid, and fluorouracil in the clinical setting: efficacy of therapy and value of serum tumor markers. PMID: 12025890 Ref: High-dose 5-fluorouracil / folinic acid in combination with three-weekly mitomycin C in the treatment of advanced gastric cancer. A phase II study. PMID: 12119460 Ref: [Clinical study on patients with advanced gastric cancer treated with oxaliplatin combining with hydroxycamptothecine]. PMID: 12478899 Ref: [Progress in postoperative adjuvant chemotherapy in gastric cancer]. PMID: 12506470 |
Ref: [Patient with stomach cancer with metastases. What is the value of chemotherapy?]. PMID: 14724998 |
Ref: A randomized trial of 5-fluorouracil, leucovorin, cisplatin and epirubicin (PELF) versus 5-fluorouracil, leucovorin and etoposide (ELF) given as adjuvant chemotherapy to patients with resected advanced gastric adenocarcinomas. PMID: 17415824 |
Ref: Orofacial and gastrointestinal hyperplasia and neoplasia in smad4+/- and elf+/-/smad4+/- mutant mice. PMID: 15610403 Ref: Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer. PMID: 15942629 Ref: The role of PRAJA and ELF in TGF-beta signaling and gastric cancer. PMID: 16096365 Ref: Inactivation of ELF/TGF-beta signaling in human gastrointestinal cancer. PMID: 16158060 Ref: Folinic acid, 5-fluorouracil and etoposide after curative resection for gastric cancer. PMID: 16201130 |
Ref: TGF-beta signaling pathway inactivation and cell cycle deregulation in the development of gastric cancer: role of the beta-spectrin, ELF. PMID: 16650383 |
Ref: Cost-effectiveness analysis of chemotherapy for advanced gastric cancer in China. PMID: 18461656 |
Ref: [Oxaliplatin combined with ELF regimen in the treatment of patients with advanced gastric cancer]. PMID: 19538878 |
Ref: Local recurrence of gastric cancer after total gastrectomy: an unusual presentation. PMID: 23173846 Ref: Clinicopathologic characteristics and survival outcomes of patients with advanced esophageal, gastroesophageal junction, and gastric adenocarcinoma: a single-institution experience. PMID: 23300355 |
Ref: Anaplastic Lymphoma Kinase Rearrangement in Digestive Tract Cancer: Implication for Targeted Therapy in Chinese Population. PMID: 26678488 |